IXC 2.86% 7.2¢ invex therapeutics ltd

There were rumours post phase 2 that a big pharma were going to...

  1. 1,386 Posts.
    lightbulb Created with Sketch. 281
    There were rumours post phase 2 that a big pharma were going to snap them up but the FDA blocker was an issue hence they decided to go down the EMA road. Since then they have sourced their own drug formulation in Korea and focussed on getting the drug to market which is I believe was the best move for the company as there is a billion dollar market there to tap into. Post phase 3 readout may still open up buyout offers which Duthy is a pro at and hopefully by then the FDA pull their finger out and give us approvals.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.002(2.86%)
Mkt cap ! $5.411M
Open High Low Value Volume
7.2¢ 7.2¢ 7.2¢ $1.701K 23.62K

Buyers (Bids)

No. Vol. Price($)
2 76375 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 5000 1
View Market Depth
Last trade - 15.42pm 13/09/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.